Spinal motor axons traverse large distances to innervate target muscle, and thus require local control of cellular events for proper functioning of the distal axon. To interrogate axon-specific processes we developed Axon-seq, a refined method incorporating microfluidic devices and stringent bioinformatic quality controls. Axon-seq demonstrates improved sensitivity and accuracy in whole-transcriptome sequencing of axons compared to previously published studies. Importantly, we show that axon transcriptomes are distinct from those of somas, displaying fewer detected genes and no contaminating astrocytic markers. We identified >5,000 transcripts in stem cell-derived spinal motor axons required for local oxidative energy production and ribosome generation. Axons contained unique transcription factor mRNAs, e.g. Ybx1, with implications for local axonal functions. Crosscomparison with peripheral sensory neuron datasets identified a common axon transcriptome consisting of 1,750 mRNAs, as well as 396 mRNAs unique to motor axons, which included genes for ribogenesis, vesicle transport and mRNA splicing. As motor axons degenerate in amyotrophic lateral sclerosis (ALS), we investigated their response to the disease-causing SOD1 G93A mutation, identifying 121 ALS-dysregulated transcripts. Several of these are implicated in axonal and dendritic outgrowth, including Nrp1, Dbn1, and Nek1, a known ALS-causing gene. In conclusion, Axon-seq proves a robust and improved method for RNA-seq of axons, furthers our understanding of peripheral axon biology, and identifies novel therapeutic targets to maintain neural connectivity in disease.
INTRODUCTION
Spinal motor neurons (MNs) are highly polarized cells. Their somas and associated dendrites are located in the spinal cord, while their axons traverse the body and connect to distal muscle fibers. The large distance between MN somas and their pre-synapse implies that the distal axon must contain a micro-environment able to independently respond to internal and external triggers. Fast-anterograde transport in axons carries vesicles with transmembrane proteins at rates up to 400 mm per day.
However, vesicles containing proteins and RNAs travel considerably slower, at 0.1-10 mm per day (Lasek et al., 1984) . Thus, protein transport alone would not suffice to sustain the dynamics of an axon and synapse, implying a strong role for local regulation. Indeed, it is well established that local RNA translation in the synapse is important for temporal control of protein synthesis and synaptic plasticity (Holt and Schuman, 2013) .
Motor axons and their specialized synapses with muscle, termed neuromuscular junctions (NMJs), are primary targets in the lethal disease amyotrophic lateral sclerosis (ALS). MNs undergo progressive degeneration in ALS, resulting in denervation of muscle, paralysis and ultimately death at 3-5 years post-diagnosis (Swinnen and Robberecht, 2014) . Notably, MNs follow a distinct 'dying-back' pattern of degeneration in ALS. Muscle denervation and axonal retraction occur before MN somas in the spinal cord are lost, implying that the NMJ is a highly vulnerable entity of the MN (Comley et al., 2016; Fischer et al., 2004; Valdez et al., 2012) . Mutations in several genes such as SOD1, C9orf72, TARDBP (TDP43) and FUS have been discovered to cause ALS (DeJesus-Hernandez et al., 2011; Kwiatkowski et al., 2009; Renton et al., 2011; Rosen et al., 1993; Sreedharan et al., 2008; Vance et al., 2009 ). However, expression of these genes is not restricted to MNs. Why and how they selectively affect MNs in ALS is not clear. Therefore, studying the RNA composition of the distal axon of this vulnerable neruon subtype may illuminate mechanisms driving the specific dying-back degeneration observed in ALS.
Previous efforts to examine axons in isolation in vitro have used either cell culture insets, Campenot chambers or microfluidic devices (Boyden, 1962; Campenot, 1977; Taylor et al., 2005) . While these are excellent tools for separating axons from somas, residual cross-contamination between the compartments still occurs. In this way, RNA-sequencing efforts aimed at isolating an axonal transcriptome profile (Briese et al., 2016; Gumy et al., 2011; Minis et al., 2014; Rotem et al., 2017; Saal et al., 2014; Taylor et al., 2009 ) can be easily undermined by a failure to carefully examine the purity of axonal fractions. Due to unappreciated technical difficulties, which are not always acknowledged, axonal fractions are often heavily contaminated with other cellular components or nonneuronal cells (Rotem et al., 2017) or the sequencing data is of poor quality (Briese et al., 2016) , likely due to the meager mRNA pool present in axons. To accurately investigate motor axon mRNA composition and its modulation in ALS we developed Axon-seq, a novel application of our single-cell RNA-preparation technique (Nichterwitz et al., 2016) to microfluidic devices housing mESC derived MNs. In contrast to previous methodologies, Axon-seq does not require RNA isolation, and allows high sensitivity, cost-efficient sequencing from a single microfluidic device. Importantly, Axon-seq utilises a stringent and sensitive bioinformatic quality control step that identifies samples containing trace levels of mRNA from undesired cell somas, effectively eliminating all cellular crosscontamination.
We derive wild type or ALS (mutated SOD1 G93A ) MNs from mouse embryonic stem cells (mESCs)
harboring the MN specific reporter Hb9::eGFP. Using Axon-seq, we show that a pure axonal transcriptome consists of roughly 5,000 mRNA species, compared to >15,000 in cell somas.
Approximately 10% of the axonal transcriptome was enriched in the axonal versus the somatodendritic compartment, including transcripts involved in energy production, translation and distinct transcription factor mRNAs such as Ybx1. We also reveal 1,750 mRNAs common to peripheral axons by comparing axonal transcriptome data sets across central and peripheral neuron types. This analysis further decoded a motor axon specific set of 396 mRNAs. Application of Axonseq to ALS axons uncovered 121 dysregulated transcripts compared to controls, of which several are important for proper neuronal and axonal functioning. Finally, a cross-comparison with axons after
Smn knockdown, a model for the motor neuron disease spinal muscular atrophy (SMA), revealed that axon guidance receptor neuropilin 1, was downregulated in axons across both MN diseases. S1A ). This indicates that MNs of a lateral motor column (LMC) identity, which are patterned by Hox genes, were generated (Dasen et al., 2008) . Consistent with this, mRNAs of multiple members of the of Hox1-8 families, which define a cervical to thoracic identity, were detected. Further, expression of the transcription factor Phox2b indicates that a proportion of brainstem MNs are also generated
RESULTS

Axon
After plating cells in microfluidic devices, MN axons were recruited to the vacant chamber by a gradient of GDNF and BDNF ( Fig 1A, E ). An initial concentration of 50 ng/ml of GDNF/BDNF was followed by a lower concentration of 5ng/ml once axons had crossed the microchannels, as this avoided growth cone collapse (Fig. 1A ). The HB9::eGFP reporter signal was detectable in MN axons, as well as in somas where it co-localized with the MN marker Islet1/2 ( Fig.   1B ). We next stained for Map2 ( Fig. 1C) and Mapt (Fig. 1D ). In mature neurons, Map2 labels dendrites, while Mapt labels axons (Garner et al., 1988; Litman et al., 1993) . The majority of processes extending across the channels were Mapt-positive, while a minority were Map2-positive, thus axonal processes were enriched in this compartment ( Fig 1C-D) . MN cultures derived from mESCs also contain interneurons. However, since a very low proportion of GFP-negative (and Maptpositive) axons appeared in the axonal compartment, we here-on refer to axonal preparations as motor axons.
Adding different media volumes to the microfluidic compartments can generate a fluid flow that counteracts diffusion (Mills et al., 2018; Taylor et al., 2005) . Using this principle, axonal or somatodendritic samples were lysed without affecting the opposite compartment ( Fig. 1F ). Further, both compartments could be effectively lysed using 2% triton X-100 in water ( Fig. 1E, F) , eliminating the need for RNA purification. To boost final RNA concentration and thereby allow sequencing from an individual microfluidic device, we introduced a vacuum centrifugation concentration step, allowing the entire lysate to be used for subsequent cDNA library preparation. Using this cost-efficient approach, we successfully conducted polyA-based RNA-seq on axonal and soma samples from individual devices using the Smart-seq2 protocol (Picelli et al., 2013) with some minor modifications (Nichterwitz et al., 2016) .
We next implemented a crucial bioinformatics-based quality control step (Axon-seq QC) to exclude axon samples displaying trace levels of cross-contamination from the adjacent compartment. First, to be considered for further analysis, samples were required to display at least 300,000 mapped reads, a minimum of 0.4 correlation to at least one other sample, and more than 2,500 detected genes (See Methods). Secondly, we performed principal component analysis (PCA) based on all expressed genes. In this analysis PC1 strongly reflected the number of detected genes, where axonal transcriptomes occupied the lower ranges, and somatodendritic samples occupied the higher ranges ( Figure 1H ). Three axonal samples displayed 7,539, 8,485 and 7,760 detected genes and occupied mid PC1 ranges. These samples were likely contaminated with one or more somas, and were discarded. Remaining high quality axon samples contained roughly 3,500 detected genes at > 1 RPKM and 5,000 detected genes at > 0.1 RPKM, while somatodendritic samples contained approximately three times these numbers ( Fig. 1G ). Axonal samples also displayed fewer detected genes when compared to single MNs (Nichterwitz et al., 2016 ) (Supplemental Fig. S1D ). Interestingly, despite this difference, cDNA yield was comparable between axonal samples and single MNs (Supplemental Fig. S1C ), suggesting that i) the cDNA yield from all axons in a microfluidic device approaches that of at most only a few cells, and ii) low numbers of detected genes in these samples is not a technical artefact, and is instead a trait unique to the axonal transcriptome. Given that Axonseq libraries display lower numbers of detected genes than do single cells, a single contaminating cell has potential to drastically and unacceptably alter the readout of an axonal library. We find that consideration of the number of detected genes is perfectly suited to identifying these contaminated samples, allowing further downstream analysis on only pure Axon-seq samples.
After QC, we then sought to compare our Axon-seq dataset to previously published methods, selecting two RNA-seq studies ( Supplemental Table S2 ) that used either cell culture insets (Rotem et al., 2017) or single microfluidic devices (Briese et al., 2016) to isolate motor axon transcriptomes.
Expression of neuronal markers in all samples was visualized in a heatmap, including e.g.
neurofilaments, peripherin, Mapt, Gap43 and the glial markers Gfap, Aqp4, Eaat1, Iba1, Ccl3, Pdgfra, Sox10 and Mog (Fig. 1I ). This analysis clearly demonstrates that Axon-seq samples expressed robust levels of neuronal and axonal markers, while being devoid of glial markers. Furthermore, our axon samples clustered away from both our somatodendritic, and our cross-contaminated axon samples, which were instead intermingled with the axon samples from previously published studies ( Fig. 1I) .
Further cross-comparison of our axon samples with a published data derived from purified neuronal samples (Zhang et al., 2014) confirmed their purity (Supplemental Fig. 1B ). Importantly, our Axon-seq samples expectedly displayed a far lower number of detected genes than the previously published axon samples ( Fig. 1I , top color bar). Thus, samples displaying poor quality and/or soma contamination were successfully identified through application of Axon-seq QC and our analysis demonstrates that the Axon-seq methodology is superior to previously published methods.
In summary, our analysis demonstrates the importance of extensive QC of axon transcriptome data with particular consideration for the number of detected genes, and presents Axon-seq as a robust and improved method for RNA-seq of pure axonal fractions from a single microfluidic device with sensitivity similar to single cell sequencing.
Axons have a unique transcriptional profile and are particularly enriched in transcripts important for mitochondrial and ribosomal functions
We next sought to compare the transcriptome of the axonal fraction against the somatodendritic fraction. When considering transcripts present in at least 3 out of 5 axonal samples, the axonal transcriptome comprised 4,238 genes ( Supplemental Table S3 ). 10,406 genes were differentially expressed between axons and somas. The majority of these (9,762) were enriched in the soma, while 644 transcripts were axon-enriched ( Supplemental Table S4 ). Moreover, analysis of the top 100 differentially expressed genes in axons and somas respectively, clearly demonstrated that axons are not simply diluted somas, but instead have a unique mRNA profile (Supplemental Fig S1E) . Principle component analysis based on all expressed genes clearly distinguished axons from somas, with PC1 explaining 41.7% of the variance ( Fig. 2A) . The top 20 genes determining PC1-negative loading and thereby axonal identity, included several genes involved in the mitochondrial respiratory chain (Cox6a1, Cox6b1, Cox8a, Cox4i1, Ndufa3, Ndufa7, Ndufb9, Ndufb11, Uqcrq) , others in mitochondrial ATP synthesis (Atp5k, Atp5j2), ribosome subunits and transcriptional elongation (Rpl41, Tceb2), cytoskeleton organization (Tmsb10), copper delivery (Atox1) and mRNA splicing (Ybx1) (Fig. 2B) . The PC1-positive loading ( Fig. 2A) was strongly influenced by transcripts present in somas that were completely absent in axons. In total, 2,903 genes were expressed at an average of RPKM > 1 in somas, that were undetectable in axons (Supplemental Fig S1F) . Gene set enrichment analysis (GSEA) on axonal enriched genes uncovered pathways related to local translation (Fig. 2C , E), mitochondrial oxidative energy production ( Fig. 2D ) and nonsense-mediated decay (Fig. 2F ). Both nuclear-or mitochondrial encoded transcripts were enriched in axons ( Fig. 2G, H) , while the ten most abundant axon-enriched transcripts were related to mitochondrial energy production ( Fig. 2I ).
Immunocytochemistry of motor axons demonstrated that also the Cox6a1 protein, which is part of the electron transport chain, was readily detected in axons ( Fig. 2J ).
In summary, our data shows that the axons of growing MNs are enriched for mRNAs related to ribosomes and mitochondrial oxidative phosphorylation, a large majority of which are mitochondrially produced. The distal axon compartment can thereby sustain local translation machinery and high energy metabolism, reflecting the enormous energy demands of growing axons.
Motor axons show a unique transcription factor profile
Analysis of the top 50 most prevalent transcription factor mRNAs in each of the two compartments uncovered 16 transcription factors were common to both compartments, including Ybx1, Carhsp1 and Sub1 (Fig. 3A,B) . Notably, the majority of soma-enriched TFs mRNAs were more abundant in somas than most axon-enriched TFs were abundant in axons (Fig. 4B ). However, five of the ten most abundant axonal TF mRNAs were significantly enriched in this compartment compared to somas,
including Ybx1, Carhsp1, Pbx4, Hmga1 and Zfp580 (Fig. 3C ). The enrichment of Ybx1 (Y-box binding protein 1, p < 0.001) ( Fig. 3C ) was particularly compelling since Ybx1 partakes in e.g. pre-mRNA transcription and splicing, mRNA packaging and regulation of mRNA stability and translation (Lyabin et al., 2014a; Lyabin et al., 2014b) . Immunocytochemistry confirmed Ybx1 protein's localization to motor axons (Fig. 3D) , strengthening a possible role for Ybx1 in supporting local regulation of distal axonal cellular processes.
In summary, axons show a unique transcription factor profile which is expected to reflect functions particular to this compartment, and that could potentially function as communication and control signals between somas and their long range axonal projections.
Cross comparison of axonal data sets across neuronal subtypes reveals both motor neuronenriched and pan-neuronal axon mRNA repertoires
To understand which mRNAs define growing axons in general and which are specific to motor axons, we compared our Axon-seq motor axons with three published axon datasets derived from primary embryonic mouse MNs (Saal et al., 2014) , or primary embryonic mouse dorsal root ganglia (DRG) (Gumy et al., 2011; Minis et al., 2014) . We selected the top 5,000 expressed transcripts from each dataset. Importantly, more than half (3,172) of the 5,000 genes identified in Axon-seq motor axons were shared with primary motor axons. Of these 3,172 genes, 396 were excluded from DRG axons and are, thereby, motor axon specific ( Fig 4A) . Each group contained a unique mRNA repertoire, but the four groups also shared 1,750 genes. GO term analysis of these 1,750 pan-axonal genes identified once again biological processes such as translation, electron transport chain, anterograde axonal transport, proteasome-mediated catabolic processes, synaptic vesicle transport and mRNA splicing ( Fig. 4B, supplemental table S5 ). Full gene lists for the common, DRG-specific and MNspecific transcripts can be found in supplemental table S6.
Finally, we conducted STRING analysis on the 396 motor axon-specific and 427 DRG axon-specific transcripts (Fig. 4C, Supplemental Fig S2, 3) to identify possible protein-protein interaction networks.
Notably, for motor axons we identified distinct gene clusters involved in ribogenesis, vesicle transport and mRNA splicing (Fig. 4C, Supplemental Fig. S2 ), putative candidates for selective MN axon function.
In summary, our analyses have identified a general axonal transcriptional signature as well as defined a unique motor axon code which gives clues to function as well as their particular susceptibility in disease.
The ALS-causative mutation SOD1 G93A modulates the axonal transcriptome
Motor axons are early pathological targets in the lethal MN disease ALS, where die-back pathology begins in the distal axon. We therefore investigated if overexpression of an ALS causative mutation (SOD1
G93A
) would induce changes in the axonal transcriptome. MNs derived from mESCs overexpressing human SOD1 G93A have high levels of SOD1 protein in somas and axons (Fig. 5A ).
Axon-seq of SOD1 G93A axons identified 4,479.5 ± 1327.7 genes at RPKM > 1 and 6,568.8 ± 2293.1 at RPKM > 0.1 ( Supplemental table S7 ). Human mutant SOD1 was highly expressed in somas and axons ( Fig. 5B) at levels approximately 10-fold higher than mouse Sod1 (Fig. 5C ). Interestingly, mouse Sod1 mRNA levels were higher in axons than in soma (p < 0.001), likely reflecting the important role of this enzyme in converting reactive superoxide radicals produced in the abundant axonal mitochondria. Mutant SOD1 overexpression resulted in differential expression of 121 genes in axons compared to the control line, of which 96 were upregulated in SOD1 G93A axons, while 25 were reduced ( Fig. 5D , Supplemental Table S8 ). Strikingly, all but two of these genes (Zfand1 and Zfp688)
were uniquely dysregulated in mutant axons and were not differentially expressed between the control and SOD1 G93A soma compartments. Moreover, many of these genes have previously been implicated in general neuronal function as well as in ALS pathology (Fig. 5E ). For instance, we found that Finally, we wanted to elucidate if any of the transcripts that were dysregulated by the SOD1 G93A mutation were affected across motor neuron diseases. We therefore compared our RNA sequencing data with a microarray data set on motor axons in which the Smn gene was knocked down to model the disease spinal muscular atrophy (Saal et al., 2014) . Sixteen transcripts were regulated across the two disease models. However, 15 genes were regulated in the opposite direction between the ALS and the SMA disease models, while one transcript, the axon guidance receptor Neuropilin 1 (Nrp1), was down-regulated in both motor neuron disease models (Fig. 5F ).
In summary, application of Axon-seq methodology to a mutant SOD1 overexpression model of ALS identified dysregulation of 121 axonal specific transcripts, some of which appear detrimental, while others may indicate compensatory mechanisms to counteract any induced dysfunction. Nrp1 was downregulated in motor axons across ALS and SMA disease models and might have implications for pathology.
DISCUSSION
Axonal RNA biology is increasingly implicated in ALS, and studies of this subcellular compartment have faced significant methodological challenges (Briese et al., 2016; Rotem et al., 2017) . In this study, we developed Axon-seq, an improved method allowing isolation and interrogation of the transcriptome of distal motor axons. We show that with careful bioinformatic QC, this cost-effective and sensitive methodology can reliably yield high quality, and pure axonal transcriptomes free of contaminating astrocytic or soma restricted transcripts. We detected >5,000 mRNA transcripts in axons, as opposed to somas, where we detected > 15,000 transcripts. Differential gene expression
shows that the axonal compartment is not simply a dilution of the soma compartment, and is instead enriched for mRNAs coding for mitochondrial energy production and ribosomes. This distinct profile reflects the high energy-dependence of growing axons and the importance of local protein translation to react to the local environment. For instance, during axon guidance the growth cone responds to guidance cues through local protein synthesis, which is required for directional turning and collapse response (Campbell and Holt, 2001) . In fact, axonal protein synthesis in chick sympathetic axons was shown to account for 5% of the total protein synthesis of the cell (Lee and Hollenbeck, 2003) .
Furthermore, transcripts for all essential subunits of the proteasome system (Psma1-7 and Psmb1-7)
were present in motor axons ( Supplemental Table S3 ). Many regulatory subunits and chaperones were also detected, implying extensive regulation of protein degradation in axons. Given that small amounts of RNA can be translated into multiple protein copies, maintaining in neuronal processes an mRNA pool poised for translation both saves energy, and increases capacity for a rapid response.
Moreover, some proteins may be toxic during transport and producing these locally would avoid any detrimental effects (Besse and Ephrussi, 2008; Du et al., 2007) .
The two largest groups of mRNAs identified in axons through GO term analysis and gene set enrichment analysis (GSEA) were mitochondrially-encoded mRNAs involved in energy production and mitoribosomes. As mitochondria are abundant in axons, and assuming there exists no bias in soma to axon transport of mitochondrially-encoded RNAs, we speculate that these mRNAs are locally transcribed. This would be consistent with our finding that nuclear encoded mRNAs for energy production, and in particular nuclear encoded ribosomal RNAs, were less abundant in axons compared to mitochondrially encoded genes, and in agreement with previous reports also describing a predominance of mitochondrially encoded genes in DRG axons (Minis et al., 2014) . Mitochondria can replicate by fission in peripheral axons (Amiri and Hollenbeck, 2008) . a process that would be facilitated by local transcription and translation of mitochondrially encoded proteins Interestingly, our data suggests that in fact the complete mRNA library required for mitochondrial replicative fission and function is present locally in axons, in part through a significant contribution from local axonal transcription.
Transcription factors, induced by local morphogens, define the identity of neurons during early development and are later often required for neuronal survival (Kadkhodaei et al., 2013; Sgado et al., 2006) . Particular transcription factors have recently been shown to have functions outside of the cell soma and to be important in neuronal circuitry plasticity, axon pathfinding and neuroprotection (Sugiyama et al., 2008; Torero Ibad et al., 2011; Wizenmann et al., 2009 ). In fact, multiple studies have identified axonal mRNAs for transcription factors, in addition to nuclear transport machinery and the nuclear envelope, whose local translation and subsequent signaling to the soma appear vital to axon maintenance and survival in injury paradigms (Ben-Yaakov et al., 2012; Cox et al., 2008; Hanz et al., 2003; Ji and Jaffrey, 2012; Yoon et al., 2012) . Axon-seq detected a specific set of transcription factor mRNAs enriched in distal MN axons compared to somas, including the RNA-binding factor
Ybx1. YBX1 has known roles in binding and stabilizing cytoplasmic mRNAs as well as in regulating translation by affecting the interaction between eukaryotic initiation factors and mRNAs (Lyabin et al., 2014b) . YBX1 was also shown to mediate the anterograde axonal transport of transcripts of the mitochondrial protein, Cox4 (Kar et al., 2017) . Interestingly, in this function YBX1 was shown to interact with FUS, an RNA binding protein and known ALS-causing gene. We expect that YBX1 and other axonally located transcription factors identified here will emerge as important mediators of communication between somas and axons.
'Dying-back' pathology in vulnerable MNs imply that the distal axonal compartment undergoes pathological changes during ALS. Axon-seq on motor axons harbouring the ALS-causative mutation SOD1 G93A uncovered differential expression of 121 mRNAs, several of which are crucial for neuronal function, axon maintenance and growth. For example, a number of the transcripts that were upregulated in SOD1 G93A axons appear detrimental, including; Adgr1, which can induce apoptosis and cause reduction in neurite outgrowth (Zuko et al., 2016) . Furthermore, multiple transcripts that are important for axon function were downregulated or absent in SOD1 G93A axons, including; Dbn1 which is important for axon initiation, growth and guidance, (Lin and Koleske, 2010; McIntyre et al., 2010; Sharma et al., 2012) , Nrp1 (Neuropilin 1) which is a semaphorin receptor involved in both axon guidance and subcellular target recognition (Telley et al., 2016) ; and Mgrn1 a ubiquitin-ligase, which appears important for mitochondrial function and neuronal survival . Mgrn1
has previously been shown to be downregulated in SOD1 mice, as well as being recruited to SOD1positive inclusions . Nrp1 is important for limb innervation (Huettl et al., 2011) , and it's downregulation here would align with a loss of NMJ function It is noteworthy that Nrp1 was downregulated in motor axons across SMA and ALS disease models. This indicates that NRP1 might be a target that could be modulated in both diseases with potential beneficial results.
Interestingly, the SOD1 mutation also caused an upregulation of transcripts that could be beneficial to axons, possibly through compensatory mechanisms aimed at preventing axon damage or dysfunction that are in play in SOD1 G93A axons. Induced transcripts with potential beneficial properties included;
Dhx36, an ATP-dependent helicase, which mediates dendritic localization of miRNA 134 with consequent effects on synaptic protein synthesis and plasticity (Bicker et al., 2013) ; F3 (contactin 1), a cell adhesion molecule involved in neurite outgrowth (Bizzoca et al., 2009) ; Rbpms, an RNA-binding protein with importance for RNA-granule localization and dendritic arbor complexity, as shown in retinal ganglion cells (Hornberg et al., 2013) ; Farp1, a marker for LMC MNs which positively regulates dendrite growth (Zhuang et al., 2009) ; Nek1, which has a putative role in microtubule stability, neuronal morphology and axon polarity. Interestingly, loss of function variants of NEK1 confer susceptibility to ALS in humans (Kenna et al., 2016) .
In summary, we have developed Axon-seq, a refined method with improved sensitivity for RNA sequencing on axons, which contains crucial bioinformatics quality control steps to identify high quality and high purity axon transcriptomes. Using Axon-seq, we demonstrate that motor axons contain a distinct repertoire of mRNAs, typified by a lower number of detected genes when compared to somas, and high enrichment for transcripts required for local energy production and protein translation. We further show that a subset of these is shared with axons of other neuronal types, underlining their importance in general axonal biology. Finally, motor axons expressing ALS-causative SOD1 G93A displayed both down-and upregulation of key transcripts involved in axonal growth and guidance, as well as neuronal survival. These differences likely represent pathological as well as compensatory processes induced by the mutation.
Due to its robustness, sensitivity and cost effectiveness, we anticipate that Axon-seq will have broad utility in the study of RNA dynamics in any polarized cell. The method will be particularly useful for the study of human neuronal processes in stem cell-derived in vitro systems. Thus far, axons of human stem cell-derived glutamatergic neurons have been isolated in microfluidic devices and screened using microarrays (Bigler et al., 2017) , but not using more advanced RNA-seq methods. Microfluidic devices have also been used to investigate axonal trafficking deficits and axonal degeneration in stem cell-derived MNs from ALS patients (Naumann et al., 2018) . In such settings, Axon-seq provides an additional layer of transcriptome-wide data, facilitating identification of the transcriptional networks underlying pathological changes in human motor axons.
EXPERIMENTAL PROCEDURES
Culturing of motor neurons in microfluidic devices
MNs were resuspended at 100,000 cells/µl and loaded into coated microfluidic devices (SND150, Xona microfluidics). Neural differentiation media was supplemented with 10 ng/ml GDNF, BDNF, CNTF and NT3, 200µM of ascorbic acid (Sigma-Aldrich), 100nM RA and 2µM 5-Fluoro-2′deoxyuridine (5FdU, Sigma-Aldrich). The axonal compartment was filled with media containing 50ng/ml of GDNF and BDNF to facilitate axonal recruitment. Media in the devices was changed daily and after 2 days, GDNF and BDNF concentrations in the axonal compartment were reduced to 5 ng/ml. In the motor neuron compartment, trophic factor concentrations were doubled from this point onwards to 20 ng/ml and RA was no longer included in the MN media.
Harvesting, library preparation and sequencing
Cultures were harvested after one week in the microfluidic devices using 2% triton X-100 (in water) and 1.5U of RNAse inhibitor (Takara). Lysis solution (75 μl) was flushed through the compartments, collected and snap-frozen on dry ice. Prior library preparation, the volume of axonal samples was reduced from ~75µl to 12-15µl using a concentrator (Eppendorf) and 10µl of the lysate used for reverse transcription. 5µl of the lysates from somatodendritic samples were directly used for the RT reaction, carried out in a final volume of 10 µl. Further steps were carried out as described (Nichterwitz et al., 2016) and samples sequenced on Illumina HiSeq2000 and -2500 platforms.
RNA-seq data processing and analysis
Reads were mapped to the mm10 mouse reference genome and the human SOD1 gene locus (hg38/GRCh38) with HISAT version 2.0.3 (Kim et al., 2015) . Aligned reads were extracted and assigned using the GenomicAlignments package (version 1.8.4, Lawrence et al., 2013) Axonal samples that clustered with soma samples in these analyses were removed.
ACCESSION NUMBERS
The original RNA sequencing data from this study are available at the NCBI Gene Expression
Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE107402. with the highest expression in axons. 5 were significantly enriched in axons, while 1 was enriched in somas. P-values are derived from differential expression between the 5 axon and 13 soma samples that passed QC and are corrected for multiple testing (mean ± SEM). (D) Immunocytochemistry for Ybx1, the most abundant transcription factor at mRNA level in axons.
FIGURES LEGENDS
Fig. 4 Cross-comparison between datasets reveals a core axonal transcriptome signature (A)
Overlap between the top 5,000 most highly expressed transcripts in axons from 4 datasets. 1,750
genes are present in all 4 datasets, possibly providing a core signature for the axonal transcriptome.
(B) GO term analysis for biological processes based on the 1,750 genes overlapping between all datasets revealed energy production, translation, vesicle processing/transport and mRNA splicing as enriched. (C) STRING analysis for protein-interactions of the 396 genes overlapping only between the motor axon samples showed distinct gene clusters involved in ribogenesis, vesicle transport and mRNA splicing. Saal et al. (Saal et al., 2014) . 16 genes are commonly dysregulated. 1 gene, Nrp1, is commonly downregulated.
